Duality Advisers, LP Invitae Corp Transaction History

Duality Advisers, LP

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022
SELL
$6.28 - $15.59 $275,742 - $684,525
-43,908 Closed
0 $0
Q4 2021

Feb 02, 2022
BUY
$14.7 - $28.67 $645,447 - $1.26 Million
43,908 New
43,908 $670,000
Q1 2021

May 13, 2021
SELL
$33.06 - $56.93 $2.04 Million - $3.52 Million
-61,824 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$39.09 - $57.4 $2.42 Million - $3.55 Million
61,824 New
61,824 $2.59 Million

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email